Glaukos
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell Glaukos and other ETFs, options, and stocks.About GKOS
Glaukos Corp. is an ophthalmic medical technology and pharmaceutical company, which focuses on novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases. It engages in development and commercialization of therapies across several end markets within ophthalmology.
GKOS Key Statistics
Stock Snapshot
With a market cap of 10.55B, Glaukos(GKOS) trades at $178.88. The stock has a price-to-earnings ratio of -54.86.
As of 2026-10-23, Glaukos(GKOS) stock has fluctuated between $173.08 and $179.70. The current price stands at $178.88, placing the stock +3.4% above today's low and -0.5% off the high.
The Glaukos(GKOS)'s current trading volume is 916.91K, compared to an average daily volume of 839.33K.
During the past year, Glaukos(GKOS) stock moved between $73.16 at its lowest and $191.62 at its peak.
During the past year, Glaukos(GKOS) stock moved between $73.16 at its lowest and $191.62 at its peak.
GKOS News
Glaukos Corporation entered an exclusive license agreement with RevOpsis Therapeutics to develop and commercialize RO-104 and up to four additional retinal biol...
Glaukos (GKOS) moved back into focus after fresh clinical data on its glaucoma and corneal therapies, as iDose TR and Epioxa each produced positive trial readou...
Analyst ratings
87%
of 15 ratingsPeople also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.